Cargando…
COVID-19: Wait for a novel drug or act with the age old drug – Do we have a choice?
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211657/ https://www.ncbi.nlm.nih.gov/pubmed/32451256 http://dx.doi.org/10.1016/j.jiph.2020.05.006 |
| _version_ | 1783531487392432128 |
|---|---|
| author | Thangaraju, Pugazhenthan gurunthalingam, Meenalotchini Prakash venkatesan, Sajitha Thangaraju, Eswaran |
| author_facet | Thangaraju, Pugazhenthan gurunthalingam, Meenalotchini Prakash venkatesan, Sajitha Thangaraju, Eswaran |
| author_sort | Thangaraju, Pugazhenthan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7211657 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72116572020-05-11 COVID-19: Wait for a novel drug or act with the age old drug – Do we have a choice? Thangaraju, Pugazhenthan gurunthalingam, Meenalotchini Prakash venkatesan, Sajitha Thangaraju, Eswaran J Infect Public Health Article The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2020-06 2020-05-11 /pmc/articles/PMC7211657/ /pubmed/32451256 http://dx.doi.org/10.1016/j.jiph.2020.05.006 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Thangaraju, Pugazhenthan gurunthalingam, Meenalotchini Prakash venkatesan, Sajitha Thangaraju, Eswaran COVID-19: Wait for a novel drug or act with the age old drug – Do we have a choice? |
| title | COVID-19: Wait for a novel drug or act with the age old drug – Do we have a choice? |
| title_full | COVID-19: Wait for a novel drug or act with the age old drug – Do we have a choice? |
| title_fullStr | COVID-19: Wait for a novel drug or act with the age old drug – Do we have a choice? |
| title_full_unstemmed | COVID-19: Wait for a novel drug or act with the age old drug – Do we have a choice? |
| title_short | COVID-19: Wait for a novel drug or act with the age old drug – Do we have a choice? |
| title_sort | covid-19: wait for a novel drug or act with the age old drug – do we have a choice? |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211657/ https://www.ncbi.nlm.nih.gov/pubmed/32451256 http://dx.doi.org/10.1016/j.jiph.2020.05.006 |
| work_keys_str_mv | AT thangarajupugazhenthan covid19waitforanoveldrugoractwiththeageolddrugdowehaveachoice AT gurunthalingammeenalotchiniprakash covid19waitforanoveldrugoractwiththeageolddrugdowehaveachoice AT venkatesansajitha covid19waitforanoveldrugoractwiththeageolddrugdowehaveachoice AT thangarajueswaran covid19waitforanoveldrugoractwiththeageolddrugdowehaveachoice |